Home/Filings/4/0001179110-19-002429
4//SEC Filing

Shafer Bradford J 4

Accession 0001179110-19-002429

CIK 0001583107other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 6:22 PM ET

Size

4.5 KB

Accession

0001179110-19-002429

Insider Transaction Report

Form 4
Period: 2019-02-20
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Transactions
  • Tax Payment

    Ordinary Shares

    2019-02-20$27.00/sh5,798$156,546183,446 total

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001302448

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 6:22 PM ET
Size
4.5 KB